HospitalsSpine

Life Spine Announces Continued Adoption and 40% Revenue Growth of PROLIFT® in the First Quarter of 2019

April 15, 2019

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company experienced significant continued growth of the PROLIFT Expandable TLIF/PLIF System in the first quarter of 2019 over the first quarter of 2018. PROLIFT saw sales growth of 40% in the same period, driven by continued clinical review and full adoption by Life Spine’s surgeon and hospital partners.

“The increasing clinical adoption of the PROLIFT system in the first quarter of 2019 is a direct result of our commitment to be one of the most innovative companies in the spinal health sector. Surgeons who have been early adopters of the product have reported an almost 100% continued adoption rate of this exciting technology among their patients, as well as continued remarkable market acceptance of PROLIFT from a growing number of surgeons using the technology for the first time,” said Mariusz Knap, Vice President of Marketing and Business Development. “We remain focused on elevating and building upon core expandable technologies with the goal of reducing surgical procedure time, reducing operating costs, and providing for better patient outcomes. Our expandable technologies, such as PROLIFT, TiBOW®, and LONGBOW®; will continue to drive our Micro-Invasive Solutions into the future.”

PROLIFT, a titanium expandable posterior interbody solution features post packing capability and our proprietary surface treatment, OSSEO-LOC™. PROLIFT allows for in-situ expansion for restoration of anatomic disc height, and decompression of neural elements. Post packing of the PROLIFT device is designed to allow for in-situ placement of bone grafting material after final placement and expansion.

“Clinical use of any new technology must be driven by a true clinical need. Through positive patient outcomes such as restoration of sagittal balance, reduced anesthesia time and hospital stay length, new technologies such as PROLIFT are fully adopted as an option for my patients” noted Richard L. Weiner, MD, of the Dallas Neurosurgical & Spine Associates in Dallas, Texas.

Life Spine’s continued focus on Micro-Invasive Technologies includes additional clinical and procedural solutions with the AVATAR® Percutaneous Screw System, SIMPACT® SI Joint Fixation, as well as the recently FDA approved CENTERLINE®Modular Posterior Fixation System.

About Life Spine

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: http://www.lifespine.com.

Life Spine is a registered trademark

Contacts

Mr. Omar Faruqi
Chief Financial Officer
ofaruqi@lifespine.com
847-884-6117

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button